Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

AbbVie Inc

AbbVie Inc

ABBV · NYSE
ABBV · NYSE

Next Earnings: 31 Jan 2025

170.70
USD0.040.02%

Analysts Recommendations

Bullish

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

168.48USD
170.70USD

52 Week Range

153.58USD
207.32USD

Market Cap

299BUSD

About

General Information

Type

Common Stock

Exchange

NYSE

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

US00287Y1091

CUSIP

00287Y109

Sector

Healthcare

Industry

Drug Manufacturers - General

Fiscal Year End

December

IPO date

-

Updated At

-

Highlights

PE Ratio

59.47

PEG Ratio

0.40

Book Value

3.41

Dividend Share

6.2

Dividend Yield

3.84%

Earnings Share

2.87

Wall Street Target Price

199.9696

EPS Estimate Current Year

10.7082

EPS Estimate Next Year

12.1852

EPS Estimate Current Quarter

2.91

EPS Estimate Next Quarter

2.95

Most Recent Quarter

-

Profitability

Revenue TTM

55,532,998,656

Gross Profit TTM

39,059,001,344

EBITDA

25,629,999,104

Profit Margin

9.22%

Return On Assets TTM

7.72%

Return On Equity TTM

56.41%

Revenue Per Share TTM

31.397

Qtly Revenue Growth YOY

3.80%

Diluted Eps TTM

2.87

Qtly Earnings Growth YOY

-12.30%

Valuation

Trailing PE

59.47

Forward PE

14

Price Sales TTM

5.431

Price Book MRQ

49.9996

Enterprise Value Revenue

6

Enterprise Value EBITDA

20

Peers analysis

  • Novo Nordisk A/S
    NVONovo Nordisk A/S

    88.08

    8.62%
  • Eli Lilly and Company
    LLYEli Lilly and Company

    787.25

    2.72%
  • AstraZeneca PLC ADR
    AZNAstraZeneca PLC ADR

    69.33

    1.04%
  • Roche Holding Ltd ADR
    RHHBYRoche Holding Ltd ADR

    38.09

    0.63%
  • Johnson & Johnson
    JNJJohnson & Johnson

    146.85

    0.15%
  • Roche Holding AG
    RHHBFRoche Holding AG

    317.34

    0.00%
  • AstraZeneca PLC
    AZNCFAstraZeneca PLC

    135.54

    -1.83%
  • Novartis AG
    NVSEFNovartis AG

    99.23

    -0.64%
  • Merck & Company Inc
    MRKMerck & Company Inc

    96.06

    -0.60%
  • Roche Holding AG Participation
    RHHVFRoche Holding AG Participation

    304.04

    -0.08%